Sequana Medical is a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer.

regulated EN NL December 23, 2025 Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan inside-information, regulated EN NL December 22, 2025 NEW …

Sequana Medical’s core technology is a fully implantable pump system designed to move excess fluid to the bladder, where it is passed naturally from the body.

Sequana Medical’s core technology is a fully implantable pump system designed to move excess fluid to the bladder, where it is passed naturally from the body.

Sequana Medical’s alfapump® system is the first and only system for the automatic and continual removal of ascites.

Company Overview “Sequana Medical is at an exciting phase in its development with clear ambitions to accelerate its commercial growth and innovation.

Aug 7, 2025 · Sequana Medical is listed on the regulated market of Euronext Brussels (Ticker: SEQUA.BR) and headquartered in Ghent, Belgium. For further information, please visit …

Sequana Medical contact details and contact form for enquiries or to request information material on the alfapump® system.

Aug 5, 2025 · Sequana Medical NV is a pioneer in treating fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer.

Mar 18, 2025 · The Company believes that such an approach may be beneficial to Sequana Medical investors through expanding the pool of potential experienced investors, while …